![Matthew Chapin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Chapin
Berater bei
Infocus Capital Partners
Profil
Matthew Chapin has held multiple positions throughout his career.
Currently, he is a Senior Vice President at Ora, Inc. since 2012 and an Advisor at Infocus Capital Partners.
Mr. Chapin completed his undergraduate degree at Bates College in 1997 and obtained an MBA from Northeastern University in 2002.
Aktive Positionen von Matthew Chapin
| Unternehmen | Position | Beginn |
|---|---|---|
Infocus Capital Partners
 Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners invests in companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for early stage capital requirements and acts as a co-investor. | Berater | - |
Ora, Inc.
 Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Corporate Officer/Principal | 01.09.2008 |
Ausbildung von Matthew Chapin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Health Technology |
Infocus Capital Partners
Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners invests in companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for early stage capital requirements and acts as a co-investor. | Finance |
